ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use
A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V

ATC code J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J05 is part of the anatomical group J Antiinfectives for systemic use.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QJ05...^[2]

Contents 1 J05A Direct acting Antiviral drugs 1.1 J05AA Thiosemicarbazones 1.2 J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors 1.3 J05AC Cyclic amines 1.4 J05AD Phosphonic acid derivatives 1.5 J05AE Protease inhibitors 1.6 J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 1.7 J05AG Non-nucleoside reverse transcriptase inhibitors 1.8 J05AH Neuraminidase inhibitors 1.9 J05AR Antivirals for treatment of HIV infections, combinations 1.10 J05AX Other antivirals 2 References

[edit] J05A Direct acting Antiviral drugs

[edit] J05AA Thiosemicarbazones

J05AA01 Metisazone

[edit] J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors

J05AB01 Aciclovir

J05AB02 Idoxuridine

J05AB03 Vidarabine

J05AB04 Ribavirin

J05AB06 Ganciclovir

J05AB09 Famciclovir

J05AB11 Valaciclovir

J05AB12 Cidofovir

J05AB13 Penciclovir

J05AB14 Valganciclovir

J05AB15 Brivudine

J05AB54 Ribavirin, combinations

[edit] J05AC Cyclic amines

J05AC02 Rimantadine

J05AC03 Tromantadine

[edit] J05AD Phosphonic acid derivatives

J05AD01 Foscarnet

J05AD02 Fosfonet

[edit] J05AE Protease inhibitors

J05AE01 Saquinavir

J05AE02 Indinavir

J05AE03 Ritonavir

J05AE04 Nelfinavir

J05AE05 Amprenavir

J05AE06 Lopinavir

J05AE07 Fosamprenavir

J05AE08 Atazanavir

J05AE09 Tipranavir

J05AE10 Darunavir

[edit] J05AF Nucleoside and nucleotide reverse transcriptase inhibitors

J05AF01 Zidovudine

J05AF02 Didanosine

J05AF03 Zalcitabine

J05AF04 Stavudine

J05AF05 Lamivudine

J05AF06 Abacavir

J05AF07 Tenofovir disoproxil

J05AF08 Adefovir dipivoxil

J05AF09 Emtricitabine

J05AF10 Entecavir

J05AF11 Telbivudine

J05AF12 Clevudine

[edit] J05AG Non-nucleoside reverse transcriptase inhibitors

J05AG01 Nevirapine

J05AG02 Delavirdine

J05AG03 Efavirenz

J05AG04 Etravirine

[edit] J05AH Neuraminidase inhibitors

J05AH01 Zanamivir

J05AH02 Oseltamivir

[edit] J05AR Antivirals for treatment of HIV infections, combinations

J05AR01 Zidovudine and lamivudine

J05AR02 Lamivudine and abacavir

J05AR03 Tenofovir disoproxil and emtricitabine

J05AR04 Zidovudine, lamivudine and abacavir

J05AR05 Zidovudine, lamivudine and nevirapine

J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz

[edit] J05AX Other antivirals

J05AX01 Moroxydine

J05AX02 Lysozyme

J05AX05 Inosine pranobex

J05AX06 Pleconaril

J05AX07 Enfuvirtide

J05AX08 Raltegravir

J05AX09 Maraviroc

[edit] References

v • d • e DNA virus Antivirals (primarily J05, also S01AD and D06BB) Baltimore I Herpesvirus DNA synthesis inhibitor TK activated Purine analogue guanine (Aciclovir#/Valaciclovir, Ganciclovir/Valganciclovir, Penciclovir/Famciclovir) adenine (Vidarabine, Cytarabine) Pyrimidine analogue uridine (Idoxuridine, Trifluridine, Edoxudine) thymine (Brivudine) Not TK activated Foscarnet Other Docosanol · early protein (Fomivirsen) · Tromantadine HPV/MC Imiquimod/Resiquimod · Podophyllotoxin Vaccinia assembly: Rifampicin Poxviridae Methisazone Hepatitis B (VII) Nucleoside analogues/NARTIs: Entecavir · Lamivudine · Telbivudine · Clevudine Nucleotide analogues/NtRTIs: Adefovir · Tenofovir Multiple/general Nucleic acid inhibitors Cidofovir Interferon Interferon alfa-2b · Peginterferon alfa-2a Multiple/unknown Ribavirin#/Taribavirin† ErbB2/PI3K Pathway NOV-205§ · NOV-002† #WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III

v • d • e Antiviral drugs: antiretroviral drugs used against HIV (primarily J05) Entry/fusion inhibitors (Discovery & development) gp41 (Enfuvirtide) · CCR5 (Maraviroc, Vicriviroc†, PRO 140†) · CD4 (Ibalizumab†) Reverse transcriptase inhibitors (RTIs) Nucleoside & Nucleotide (NRTI) Nucleoside analogues/NARTIs: Abacavir (ABC)°# · Emtricitabine (FTC)°# · Lamivudine (3TC)°# · Didanosine (ddI)# · Zidovudine (AZT)# · Apricitabine† · Stampidine† · Elvucitabine† · Racivir† · Amdoxovir† · Stavudine (d4T)# · Zalcitabine (ddC)◊ Nucleotide analogues/NtRTIs: Tenofovir°# Non-Nucleoside (NNRTI) (Discovery & development) (1st gen) Efavirenz°# · Nevirapine#  · Loviride◊ · Delavirdine◊ · (2nd gen) diarylpyrimidines (Etravirine, Rilpivirine†)  · Lersivirine† Integrase inhibitors Raltegravir · Elvitegravir† · Globoidnan A (experimental)  · MK-2048†  · GSK-572† Maturation inhibitors Bevirimat† · Vivecon† Protease Inhibitors (PI) (Discovery & development) Atazanavir° · Fosamprenavir° · Lopinavir°# · Darunavir · Nelfinavir# · Ritonavir# · Saquinavir# · Tipranavir · Amprenavir◊ · Indinavir◊# Combined formulations Combivir · Atripla · Trizivir · Truvada · Kaletra · Epzicom Experimental agents Uncoating inhibitors TRIM5alpha (gene) Transcription inhibitors Tat antagonists Translation inhibitors Trichosanthin Other Abzyme · Calanolide A · Ceragenin · Cyanovirin-N · Diarylpyrimidines · Epigallocatechin gallate (EGCG) · Foscarnet · Griffithsin · Hydroxyurea · Miltefosine · Portmanteau inhibitors · Seliciclib† · Synergistic enhancers · Tre recombinase · Zinc finger protein transcription factor · KP-1461† Failed agents Dexelvucitabine · Capravirine · Emivirine · Lodenosine · Atevirdine · Brecanavir · Aplaviroc #WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III °DHHS preferred first-line agent. ◊Formerly or rarely used agent.